Monday, October 26, 2026 · Daily editionET --:--:--

Finished

Strategies of Therapy With the Exoskeleton Robot ARMin

NCT03100422 · Swiss Federal Institute of Technology · Updated 17 July 2020

What is being tested
ARMin; Occupational Therapy
For
Stroke
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 18 people. The full rules are on the registry page.
Where
Switzerland
When
Starts or started 1 May 2017, ends 31 Oct 2018. Registered 4 April 2017.
Results
None posted yet.

In the researchers' words

Neurological patients (e.g., after stroke) need long-term neurorehabilitation therapy of the arm with often limited, unsatisfactory outcome. Robots became a promising supplement or even alternative for neurorehabilitation training.
ClinicalTrials.gov, NCT03100422

Sites

  • Labor für Sensomotorische Systeme, ETH Zürich, Balgrist CampusZurich, Switzerland